Showing results (171-180 of 194) with videos related to

Sort By:
Pageof 20
Nature Medicine|October 19, 2023
The PD-1- and LAG-3-targeting bispecific molecule tebotelimab in solid tumors and hematologic cancers: a phase 1 trialJason J Luke, Manish R Patel, George R Blumenschein, et al.
Cancer Discovery|November 12, 2021
Adjuvant Pembrolizumab versus IFNα2b or Ipilimumab in Resected High-Risk MelanomaKenneth F Grossmann, Megan Othus, Sapna P Patel, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 12, 2021
NCCN Guidelines® Insights: Melanoma: Cutaneous, Version 2.2021Susan M Swetter, John A Thompson, Mark R Albertini, et al.
Cell Stem Cell|September 21, 2024
The landscape of drug sensitivity and resistance in sarcomaAhmad Al Shihabi, Peyton J Tebon, Huyen Thi Lam Nguyen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 20, 2026
Five-Year Survival with Tebentafusp in Metastatic Uveal MelanomaS Piperno-Neumann, P Rutkowski, J C Hassel, et al.
Nature Communications|July 2, 2025
Human cancer-targeted immunity via transgenic hematopoietic stem cell progenyTheodore S Nowicki, Nataly Naser Al Deen, Cole W Peters, et al.
Nature Medicine|August 17, 2023
Ipilimumab with or without nivolumab in PD-1 or PD-L1 blockade refractory metastatic melanoma: a randomized phase 2 trialAri VanderWalde, Shay L Bellasea, Kari L Kendra, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 18, 2014
Adoptive transfer of MART-1 T-cell receptor transgenic lymphocytes and dendritic cell vaccination in patients with metastatic melanomaThinle Chodon, Begoña Comin-Anduix, Bartosz Chmielowski, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|July 17, 2024
NCCN Guidelines® Insights: Melanoma: Cutaneous, Version 2.2024Susan M Swetter, Douglas Johnson, Mark R Albertini, et al.
Cancer Cell|September 11, 2020
Conserved Interferon-γ Signaling Drives Clinical Response to Immune Checkpoint Blockade Therapy in MelanomaCatherine S Grasso, Jennifer Tsoi, Mykola Onyshchenko, et al.
Pageof 20